Connection

Kwok-Yung Yuen to Tumor Necrosis Factor-alpha

Back to Details
This is a "connection" page, showing publications Kwok-Yung Yuen has written about Tumor Necrosis Factor-alpha.
Kwok-Yung Yuen
Connection Strength
0.086
Tumor Necrosis Factor-alpha
  1. Triple combination of FDA-approved drugs including flufenamic acid, clarithromycin and zanamivir improves survival of severe influenza in mice. Arch Virol. 2018 Sep; 163(9):2349-2358.
    View in: PubMed
    Score: 0.086
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.